Cargando…
Capecitabine and mitomycin C in patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2006
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361375/ https://www.ncbi.nlm.nih.gov/pubmed/16495915 http://dx.doi.org/10.1038/sj.bjc.6603021 |
| _version_ | 1782153201084006400 |
|---|---|
| author | Alliot, C |
| author_facet | Alliot, C |
| author_sort | Alliot, C |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2361375 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2006 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-23613752009-09-10 Capecitabine and mitomycin C in patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan Alliot, C Br J Cancer Letter to the Editor Nature Publishing Group 2006-03-27 2006-02-21 /pmc/articles/PMC2361375/ /pubmed/16495915 http://dx.doi.org/10.1038/sj.bjc.6603021 Text en Copyright © 2006 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Letter to the Editor Alliot, C Capecitabine and mitomycin C in patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan |
| title | Capecitabine and mitomycin C in patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan |
| title_full | Capecitabine and mitomycin C in patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan |
| title_fullStr | Capecitabine and mitomycin C in patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan |
| title_full_unstemmed | Capecitabine and mitomycin C in patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan |
| title_short | Capecitabine and mitomycin C in patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan |
| title_sort | capecitabine and mitomycin c in patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361375/ https://www.ncbi.nlm.nih.gov/pubmed/16495915 http://dx.doi.org/10.1038/sj.bjc.6603021 |
| work_keys_str_mv | AT alliotc capecitabineandmitomycincinpatientswithmetastaticcolorectalcancerresistanttofluorouracilandirinotecan |